Alf‐Åge R. Pettersen

High On‐Aspirin Platelet Reactivity and Clinical Outcome in Patients With Stable Coronary Artery Disease: Results From ASCET (Aspirin Nonresponsiveness and Clopidogrel Endpoint Trial)

Alf‐Åge R. Pettersen, Ingebjørg Seljeflot, Michael Abdelnoor et al. · Journal of the American Heart Association · 2012 · 80 citations · Full text

Medicine, Cardiology, Hematology +16

Beta-Blockers after Myocardial Infarction in Patients without Heart Failure

John Munkhaugen, Anna Meta Dyrvig Kristensen, Therese Lucia Friis Holmager et al. · New England Journal of Medicine · 2025 · 79 citations · Full text

Medicine, Cardiology, Pharmacotherapy +17

Unstable angina, stroke, myocardial infarction and death in aspirin non‐responders. A prospective, randomized trial. The ASCET (ASpirin non‐responsiveness and Clopidogrel Endpoint Trial) design

Alf‐Åge R. Pettersen, Ingebjørg Seljeflot, Michael Abdelnoor et al. · Scandinavian Cardiovascular Journal · 2004 · 60 citations

Medicine, Pharmacology, Pharmacotherapy +17

The influence of CYP 2C19*2 polymorphism on platelet function testing during single antiplatelet treatment with clopidogrel

Alf‐Åge R. Pettersen, Harald Arnesen, Trine B. Opstad et al. · Thrombosis Journal · 2011 · 51 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Markers of neutrophil extracellular traps are associated with adverse clinical outcome in stable coronary artery disease

Miriam Sjåstad Langseth, Trine B. Opstad, Vibeke Bratseth et al. · European Journal of Preventive Cardiology · 2018 · 49 citations · Full text

Medicine, Cardiology, Immunology +17